Subscribe in seconds and receive Life Sciences Voice's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow Life Sciences Voice: Lifescivoice - News and Insights of Life Sciences Industry
Is this your feed? Claim it!
The life sciences industry is entering a transformative decade driven by artificial intelligence, precision medicine, digital health infrastructure, and next-generation biotechnology platforms. What was once considered experimental innovation is rapidly becoming operational reality across pharmaceutical companies, biotech firms, healthcare providers, ...
Yes—AI can reduce drug development costs without proportionally increasing risk, but only when deployed within structured scientific, regulatory, and operational frameworks. In 2026, pharmaceutical and biotech companies are shifting from experimental AI adoptio...
Inhibrx Biosciences reported interim data from the phase 2 portion of its HexAgon study showing a higher objective response rate when its OX40 agonist, INBRX-106, was added to Merck & Co.’s Keytruda in patients with head and neck squamous cell carcinoma (HNSCC). The results have led the com...
SubQ Biogen and Eisai could be forced to wait another three months to hear the verdict from the FDA on their plan to begin treating patients with their anti-amyloid Alzheimer’s drug in an under-the-skin version.
The FDA has asked for more data related to the proposed use of subcutaneous Leqembi in treatment initiation as part of its drug review process, the pharma part...
The life sciences industry in 2026 is undergoing a structural shift from function-driven expertise to capability-driven performance. As AI, advanced therapeutics, and digital systems scale, the differentiating factor is no longer what professionals know—but how effectively they can apply knowledge across disciplines to drive measurable outcomes.
<...